Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
Innovative Research Reagents for Inflammation & Immune Responses
Toggle Nav
New Products Archive |
|
Latest Product Highlights ArchiveNew GDF15 Blocking Antibody for Metabolism & Aging Research
|
News & Press ReleasesIL-27 as a New Immunotherapeutic Target in chronic HBV Infection A recent study published in Nature Immunology and led by Dr. Matteo Iannacone (San Raffaele Research Institute, Italy) describes how HBV-specific CD4+ effector T cells regulate the HBV-specific CD8+ T cells during chronic HBV infection and suggests that IL-27 may have therapeutic potential. Abcalis and AdipoGen Life Sciences Partner on Distributing Animal-free Recombinant Monoclonal and Multiclonal Antibodies on the Life Science Research Market |
Collaborating with |
|